In chronic myeloid leukemia (CML), the BCR-Abl fusion protein constitutively stimulates the PI3K/Akt axis, leading to continuous mTOR activation and uncontrolled myeloid proliferation [147]. Here, MTOR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.